NCT04860505View on ClinicalTrials.gov

Combo-PEP: Multipurpose Prevention of Post-Exposure Prophylaxis Regimens

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 20, 2021

Primary Completion Date

May 9, 2022

Study Completion Date

May 9, 2022

Conditions
Sexually Transmitted Diseases
Interventions
DRUG

Doxycycline

Doxycycline (DOX \[200 mg\]) is an oral medication used to treat or prevent infections that are strongly suspected to be caused by bacteria; it is an antimicrobial drug indicated for bacterial infections such as sexually transmitted infections.

DRUG

Biktarvy

Biktarvy (200mg) is an oral combination anti-HIV medication that contains the drugs tenofovir alafenamide, emtricitabine, and bictegravir.

Trial Locations (1)

30322

Hope Clinic, Atlanta

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

lead

Emory University

OTHER